Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.

Heptaminol may cause hair lightening in hemodialysis patients.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Some stem cells in the body rarely divide, which could help create better treatments for diseases and aging.

Betamethasone oral mini-pulse therapy showed good or fair results in treating lichen planus.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

FGF21 can help reduce skin inflammation caused by C. acnes.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Gray hair can potentially be reversed, leading to new treatments.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Mast cells likely promote skin scarring and fibrosis, but their exact role is still unclear.